TECHNOLOGY

TECHNOLOGY

TECHNOLOGY

INVESTORS

INVESTORS

TECHNOLOGY

RESOURCES

RESOURCES

RESOURCES

TECHNOLOGY

TECHNOLOGY

TECHNOLOGY

TECHNOLOGY

RESOURCES

1/4

Measuring Therapy Effectiveness Through Sensing and Data Control  

 

Find out how we are transforming the medical industry through continuous sensing, computing and transmission to provide the configurable data that physicians need.

 

We've started with intraocular pressure (IOP) sensing to help assess glaucoma therapy effectiveness.

 

 

Careers

Emeryville  |  Twin Cities

Technology

 

Our smart sensor is a self-anchoring platform that interfaces well with media (blood, tissue, other fluids) without interfering with the electronics that support the sensing, computing and transmission of data.

Injectsense Wireless IOP sensor.jpg

Investors

Injectsense received Series B funding in April of 2019, and is currently engaged in fundraising for Series C. 

Events

 

American Glaucoma Society

March 3-6

Nashville

ASCRS

April 22-26, 2022

Washington, D.C.

AAO

Sep 30 - Oct 3, 2022

Chicago.

The Injectsense Difference

 

Take a look at how the company's Silicon Valley and Twin Cities product teams combine cutting-edge advances in microelectronics with best-in-class medical device development and expertise. 

CAUTION - Investigational Device. Limited by Federal law to investigational use.

.